Reflections from news and commentary of the day
Subscribe To
Posts
Comments
Friday, October 30, 2020
The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug | Science | AAAS
The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug | Science | AAAS: The Food and Drug Administration held no advisory meeting on antiviral, and the European Union signed contract without knowing of failed trial
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment